Windlas Biotech consolidated net profit declines 3.72% in the December 2025 quarter
Sales rise 19.53% to Rs 233.10 crore
Net profit of Windlas Biotech declined 3.72% to Rs 15.00 crore in the quarter ended December 2025 as against Rs 15.58 crore during the previous quarter ended December 2024. Sales rose 19.53% to Rs 233.10 crore in the quarter ended December 2025 as against Rs 195.02 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales233.10195.02 20 OPM %10.4612.63 -PBDT27.6727.28 1 PBT19.9720.34 -2 NP15.0015.58 -4Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 06 2026 | 9:08 AM IST